Lowering blood pressure in acute stroke: The SCAST trial

The Lancet

Volumn 377, Issue 9767, 2011, Pages 696-698

  Hankey, Graeme J ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN HEXETIL;

BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; BRAIN ARTERY; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HUMAN; HYPERTENSION; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

EID: 79952070465     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60163-3     Document Type: Note

References (15)

1. Sandset EC, Bath PMW, Boysen G, on behalf of the SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; published online Feb 11. DOI:10.1016/S0140-6736(11)60104-9.
2. Oliveira-Filho J, Silva SC, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A. Detrimental eff ect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003; 61: 1047-51. (Pubitemid 37461935)
3. Geeganage C, Tracy M, England T, for TAIST Investigators. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke 2011; 42: 491-93.
4. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
5. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007; 38: 1655-711. (Pubitemid 46691097)
6. Morgenstern LB, Hemphill JC III, Anderson C, on behalf of the American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral haemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41: 2108-29.
7. Aries MJ, Elting JW, De Keyser J, Kremer BP, Vroomen PC. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 2010; 41: 2697-704.
8. Geeganage C, Bath PMW. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2008; 4: CD000039.
9. Geeganage C, Bath PMW. Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2010; 7: CD002839.
10. Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009; 8: 48-56.
11. Schrader J, Lüders S, Kulschewski A, et al, on behalf of the ACCESS Study Group. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34: 1699-703. (Pubitemid 36842630)
12. Anderson CS, Huang Y, Wang JG, et al, for the INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7: 391-99.
13. Delcourt C, Huang Y, Wang J, for the INTERACT2 Investigators. The second (main) phase of an open, randomised, multicentre study to investigate the eff ectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke 2010; 5: 110-16.
14. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Int J Stroke 2006; 1: 245-49.
15. Robinson TG, Potter JF, Ford GA, et al, on behalf of the COSSACS Investigators. Eff ects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 2010; 9: 767-75.